US FDA grants 510(k) clearance to BVI Medical’s innovative glaucoma surgical system, Laser Endoscopy Ophthalmic System: Waltham, Massachusetts Monday, April 21, 2025, 15:00 Hrs ...

Adverse social determinants of health are associated with worse visual outcomes in primary congenital glaucoma.

MINT, a stent-free platform, helps treat adult patients undergoing glaucoma angle surgery. The system utilizes a unique ...

Leos is supported by emerging data from a randomized controlled clinical trial, further validating its safety and efficacy.

A survey collected demographic data, ocular and medical history, and responses assessing knowledge of glaucoma and cataracts ...

Glaucoma is often called the “silent thief of sight,” and for good reason. It’s a leading cause of irreversible blindness ...

Ophthalmic device company BVI Medical has earned FDA clearance for its new glaucoma surgical system, Leos, its brand name for the laser endoscopy ophthalmic system. Leos is the only laser system that ...

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

The FDA granted 510(k) clearance for Leos, a laser endoscopy ophthalmic system for a more intuitive laser endoscopic ...

A new study published in the journal ACS Pharmacology & Translational Science finds that cannabinoids may offer a promising ...

This clearance marks a significant advancement in glaucoma care, especially for earlier stages of the disease and across a wide spectrum of ...

The following is a summary of “Phase 3, Randomized, Comparison Study of Intracameral Bimatoprost Implant 10 µg and Selective ...